Sharemaestro Newsreel

Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study

Pulse Biosciences has announced that its NANOPULSE-AF IDE Pivotal Study, investigating its Nanosecond Pulsed Field Ablation (nano-PFA) technology for atrial fibrillation, has surpassed its enrollment midpoint since commencing in April 2026. The rapid enrollment is attributed to the enthusiasm of investigational sites for the …

Pulse Biosciences Reaches Enrollment Midpoint in NANOPULSE-AF Trial for Cardiac Treatment

Pulse Biosciences announced that its NANOPULSE-AF clinical study has reached its enrollment midpoint for the nPulse Cardiac Catheter System. This pivotal study is evaluating the technology for treating recurrent, drug-resistant, symptomatic paroxysmal atrial fibrillation. The achievement marks a significant step towards potential regulatory approval …

EMBC Deadline Alert: Levi & Korsinsky Reminds Embecta Corp. (EMBC) Investors of Securities Class Action Deadline on August 17, 2026

Levi & Korsinsky, LLP is reminding investors of Embecta Corp. (NASDAQ: EMBC) about a securities class action lawsuit with a lead plaintiff deadline of August 17, 2026. The lawsuit alleges that Embecta made misrepresentations regarding the stability of its U.S. pen needle revenue, which …

Align Technology to overhaul board following engagement with Elliott

Align Technology announced it will add three independent directors to its board and launch a comprehensive operational review after discussions with activist investor Elliott Investment Management. The strategic changes aim to improve revenue growth and boost profit margins, and the company also increased its …

Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of Dentsply Sirona Inc. (NASDAQ: XRAY) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders to contact them to discuss legal options, including seeking corporate governance reforms or …

Avantor (AVTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended June 2026, Avantor, Inc. (AVTR) reported revenue of $1.69 billion, up 0.5% over the same period last year. EPS came in at $0.21, compared to $0.24 in the year-ago quarter. The reported revenue represents a surprise of +4.17% over the …

Repligen Earnings: Excellent Profit Margins, China Recovery Underway

Avantor, Inc. Q2 2026: Revenue $1.69B, EPS $0.06— 10-Q Summary

Avantor, Inc. reported Q2 2026 results with revenue of $1.69 billion, nearly flat year-over-year, and diluted EPS of $0.06, down from $0.09 in the prior year. The company experienced margin pressure and mixed demand, leading to a decline in net income. While VWR Distribution …

Bausch + Lomb Corporation Raises Earnings Guidance for the Full Fiscal Year 2026

Bausch + Lomb Corporation has updated its earnings guidance for the full fiscal year 2026, raising its revenue expectations. The company now anticipates revenue to fall between $5.440 billion and $5.540 billion, an increase from its previous forecast of $5.420 billion to $5.520 billion.

Becton Dickinson (BDX) On Its Brazil Semaglutide Push And The Valuation Narrative

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Becton Dickinson (BDX) is back in focus after announcing a collaboration with EMS to support the launch of a semaglutide therapy in Brazil. The …

KORU Medical Systems (KRMD) Expected to Announce Quarterly Earnings on Wednesday

KORU Medical Systems (NASDAQ:KRMD) is anticipated to release its Q2 2026 earnings after the market closes on Wednesday, August 5th. Analysts project the company will report a loss of $0.02 per share and revenue of approximately $11.6 million. The company's shares opened at $4.01, …

Repligen Offers Differentiated Solutions as a Leading Bioprocessing Supplier

Repligen is highlighted as a leading provider of bioprocessing solutions for biologic drug manufacturers. The company offers a range of advanced systems including filtration, fluid management, chromatography columns, and process analytics. Despite its relatively small size, Repligen is noted for its innovation and record …

Avantor Releases Q2 2026 Financial Results

Avantor, Inc. reported Q2 2026 adjusted earnings per share of $0.21, surpassing analyst estimates by 10.5%. The company achieved $1.69 billion in revenue, a slight increase from Q2 2025, despite a 0.4% decline in organic revenue due to biopharma and research market headwinds. Avantor …

ETFs Investing in AtriCure, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold shares of AtriCure, Inc. (ATRC). It provides a comprehensive table detailing each fund's market value, weight of ATRC stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change, relative volume, and …

Canaccord reiterates Hold on Repligen stock, keeps $145 target

Canaccord Genuity has reiterated a Hold rating on Repligen Corp. (NASDAQ:RGEN) and maintained its $145 price target, believing the shares are fairly valued. The bioprocessing company exceeded analyst expectations for its second-quarter 2026 results, reporting strong revenue growth across all franchises and raising its …

Femasys Inc (FEMY) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article assesses the risk profile of Femasys Inc (FEMY), highlighting its current risk assessment score of 1.28, which ranks it 184th out of 199 companies in the Healthcare Equipment & Supplies industry. Key metrics include a beta value of -2.13, indicating defensive stock …

Earnings Flash (BLCO) Bausch + Lomb Corporation Posts Q2 Adjusted EPS $0.15 per Share, Vs. FactSet Est of $0.15

Bausch + Lomb Corporation (BLCO) announced its Q2 adjusted earnings per share (EPS) of $0.15, meeting FactSet's estimate. This financial report provides key insights into the company's performance for the second quarter.

Resmed Inc (RMD) Institutional Confidence

The article details ResMed Inc.'s institutional confidence score, which is currently 5.00, placing it 107th in its industry. Institutional shareholding increased by 3.69% quarter-over-quarter, with ETHSX being the largest holder. It also lists top institutional shareholders and their changes in holdings.

Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance

Revenue of $1.394 Billion Revenue Grew 9% as Reported and 8% on a Constant Currency1 Basis Compared to the Second Quarter of 2025 GAAP Net Loss Attributable to Bausch + Lomb Corporation of $14 Million Adjusted EBITDA (non-GAAP)1 of $241 Million; Adjusted EBITDA Excluding …

Avantor (NYSE:AVTR) Delivers Impressive Q2 CY2026, Stock Soars

Avantor (NYSE:AVTR) Delivers Impressive Q2 CY2026, Stock Soars Life sciences company Avantor (NYSE:AVTR) beat Wall Street's revenue expectations in Q2 CY2026, but sales were flat year on year at $1.69 billion. Its non-GAAP profit of $0.21 per share was 11% above analysts' consensus estimates. …

Nyxoah SA (NYXH) Financial Health: Profitability & Balance Sheet Analysis

Nyxoah SA (NYXH) currently has a financial score of 6.82, ranking 130 out of 199 in its industry, indicating a weak financial status and low operating efficiency. Despite this, its latest quarterly revenue saw a significant year-over-year increase of 529.05% and net profit rose …

Irenic Capital Management LP Takes $104.06 Million Position in Teleflex Incorporated $TFX

Irenic Capital Management LP has acquired a new position in Teleflex Incorporated, purchasing 870,000 shares valued at approximately $104.06 million, making it their third-largest holding. This move contributes to Teleflex's high institutional ownership of 95.62%, with other major investors also increasing their stakes. Despite …

A semaglutide therapy launches in Brazil with BD's injection pen

BD (Becton, Dickinson and Company) and EMS, a leading Brazilian pharmaceutical company, have collaborated to launch an EMS semaglutide therapy in Brazil using the BD Vystra™ Injection Pen platform. This partnership aims to enhance access to GLP-1 treatments for chronic metabolic diseases like obesity …

Earnings Flash (AVTR) Avantor, Inc. Posts Q2 Adjusted EPS $0.21 per Share, vs. FactSet Est of $0.19

Avantor, Inc. (AVTR) reported its Q2 adjusted EPS at $0.21 per share, surpassing FactSet's estimate of $0.19. This earnings flash highlights the company's financial performance for the second quarter of 2026. The article also mentions Avantor's Q2 revenue of $1.69 billion, exceeding the FactSet …

Avantor® Reports Second Quarter 2026 Results

Avantor, Inc. reported better-than-expected results for the second fiscal quarter of 2026, with net sales of $1,692.3 million. The company's "Revival program" and strong free cash flow generation, used to repay $112.1 million of debt, contributed to the improved performance. Avantor also increased its …

FEMY|Femasys Inc|Price:2.910|Chg%:+0.130

This article provides a comprehensive stock analysis of Femasys Inc (FEMY) from TradingKey, highlighting its healthy fundamentals, good growth potential, and fair valuation. Key insights include high institutional ownership, recent "Buy" ratings from analysts with a high price target, and expectations for an upward …

OraSure Technologies (OSUR) Expected to Post Earnings on Wednesday

OraSure Technologies (NASDAQ:OSUR) is scheduled to release its Q2 2026 earnings after market close on Wednesday, August 5th. Analysts anticipate a loss of $0.27 per share on revenue of $28.85 million. Despite a consensus "Reduce" rating and an average price target of $3.00, the …

L1 Capital (AVR) offloads 441,548 Anteris Technologies shares in July sales

L1 Capital Pty Ltd, a 10% holder of Anteris Technologies Global Corp. (AVR), reported indirect sales of 441,548 common shares on July 27-28, 2026. The sales included 232,817 shares at $8.19 and 208,731 shares at $8.09, totalling approximately $3.60 million. L1 Capital, which manages …

ICU Medical Inc (ICUI) Institutional Confidence

ICU Medical Inc (ICUI) has an institutional shareholding score of 10.00, placing it first among 199 companies in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 114.41%, a 3.95% decrease quarter-over-quarter. ETHSX is the largest institutional shareholder with 168.43K shares, representing …

Bionano Genomics Inc (BNGO) Financial Health: Profitability & Balance Sheet Analysis

Bionano Genomics Inc (BNGO) has a weak financial score of 5.95, ranking 180 out of 199 in its industry due to low operating efficiency. Despite this, its latest quarterly revenue increased by 3.56% year-over-year, and net profit saw a significant 167.67% year-over-year increase. The …

DENTSPLY SIRONA Inc (XRAY) Institutional Confidence

DENTSPLY SIRONA Inc's institutional confidence score is 10.00, placing it first in the Healthcare Equipment & Supplies industry. Institutional shareholding decreased by 9.16% quarter-over-quarter to 111.69%, with First Eagle Investment being the largest shareholder. The article lists top institutional shareholders and their recent share …

KORU Medical Systems Inc (KRMD) Financial Health: Profitability & Balance Sheet Analysis

KORU Medical Systems Inc (KRMD) currently holds a strong financial score of 8.14, positioning it robustly within the Healthcare Equipment & Supplies industry. This score reflects its high operating efficiency, evidenced by a 22.10% year-over-year revenue increase to $11.76M and a 30.80% rise in …

Pulse Biosciences Inc (PLSE) Institutional Confidence

Pulse Biosciences Inc (PLSE) has an institutional shareholding score of 3.00, placing it 130th out of 199 in the Healthcare Equipment & Supplies industry. Institutional shareholding proportion increased by 30.37% quarter-over-quarter, reaching 11.76%. The largest institutional shareholder, Bill Nygren | OAKMX, holds 6.89K shares, …

Dimensional Fund Advisors LP Has $119.26 Million Stock Holdings in Teleflex Incorporated $TFX

Dimensional Fund Advisors LP reduced its stake in Teleflex Incorporated by 20.3% in the first quarter, now holding 997,144 shares valued at $119.26 million. Several other institutional investors also adjusted their holdings, with some acquiring new positions and others increasing existing ones. Teleflex reported …

Intuitive Surgical (ISRG) Faces Global Recall Of 11,113 Da Vinci SP Drapes

Intuitive Surgical (ISRG) is facing a global Class II recall of 11,113 da Vinci SP Instrument Arm Drapes due to detachment issues that could delay procedures or require changes in surgical approach. This recall, affecting its robotic surgery platform, highlights operational and regulatory risks …

U.S. RESEARCH ROUNDUP- BioLife Solutions, Gossamer Bio, Intuit

This article summarizes changes in analyst ratings and price targets for several U.S.-listed companies as reported by Reuters on a Friday. Key changes include Stephens cutting BioLife Solutions to equal weight, Leerink Partners raising Gossamer Bio to outperform, and TD Cowen cutting Intuit to …